Investors also receive five-year warrants for 4,562,500 common shares
By Devika Patel
Knoxville, Tenn., Feb. 12 - Manhattan Scientifics Inc. settled a $1.37 million private placement of stock with two investors on Feb. 4 and Feb. 10, according to an 8-K filed Wednesday with the Securities and Exchange Commission.
The company sold 18.25 million common shares at $0.075 apiece, a 7.14% premium to the Feb. 3 closing share price of $0.07.
Investors also received warrants for 4,562,500 shares; the five-year warrants are each exercisable $0.075, also a 7.14% premium to the Feb. 3 closing share price.
The New York company operates as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields, with emphasis in the areas of nanotechnology.
| Issuer: | Manhattan Scientifics Inc.
|
| Issue: | Common stock
|
| Amount: | $1,368,750
|
| Shares: | 18.25 million
|
| Price: | $0.075
|
| Warrants: | For 4,562,500 shares
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $0.075
|
| Settlement date: | Feb. 4 and Feb. 10
|
| Stock symbol: | OTCBB: MHTX
|
| Stock price: | $0.07 at close Feb. 3
|
| Market capitalization: | $32.41 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
